Cargando...
Genetically Engineered Multivalent Proteins for Targeted Immunotherapy
Monoclonal antibodies initiated the unprecedented breakthroughs in cancer immunotherapy and are rapidly evolving with multiple therapeutic platforms. One next generation strategy engineers multivalent proteins that ligate single-chain variable fragments targeting cellular effectors, tumor-associated...
Guardado en:
| Publicado en: | Clin Cancer Res |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4947414/ https://ncbi.nlm.nih.gov/pubmed/27009744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0246 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|